Cancer anorexia: new pathogenic and therapeutic insights.
During tumor growth, anorexia and reduced food intake markedly contribute to the development of malnutrition, thus worsening overall patients' survival. A better understanding of the pathophysiology of eating behavior may lead to new and more effective therapies, aiming at counteracting the detrimental effects of anorexia and reduced food intake on nutritional status and survival in cancer patients. Brain tryptophan and serotonin concentrations seem to play a pivotal role in the regulation of eating behavior. Increased brain serotonin activity is indeed associated with a reduction of food intake. It has been recently hypothesized that increased availability of tryptophan to the brain and the consequent increased serotonin activity may represent the pathogenic mechanism for cancer-associated anorexia. According to this hypothesis, the modulation of brain serotonin activity may result in an improvement of anorexia. Reducing brain tryptophan availability represents a possible mechanism to restore brain serotonin activity to normal. There is evidence that the oral administration of neutral amino acids competing with tryptophan for brain entry results in a significant improvement of cancer anorexia. The same treatment may also be effective in improving secondary anorexia, which is associated with other chronic illnesses, including renal and liver failure, sepsis, and so forth, sharing a similar pathogenic mechanism.
Cangiano
C
C
Department of Clinical Medicine, University La Sapienza, Rome, Italy.
Laviano
A
A
Muscaritoli
M
M
Meguid
M M
MM
Cascino
A
A
Rossi Fanelli
F
F
D000818:Animals; D000855:Anorexia / Q000209:etiology* / Q000503:physiopathology* / Q000628:therapy; D016207:Cytokines / Q000502:physiology; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D012701:Serotonin / Q000502:physiology; D014364:Tryptophan / Q000502:physiology
D016207:Cytokines; D012701:Serotonin; D014364:Tryptophan